Global Immunology Market 2023-2027

Description

List of Tables

The immunology market is forecasted to grow by USD 56.07 bn during 2022-2027, accelerating at a CAGR of 8.84% during the forecast period. The report on the immunology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing organ transplantation, growing cases of infectious diseases, and hurdles in the approval of biosimilars.

Technavio's immunology market is segmented as below:

By Type

Immunosuppressants
Immuno boosters

By Distribution Channel

Hospital pharmacies
Retail pharmacies
Online pharmacies

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the significant pipeline of immunology as one of the prime reasons driving the immunology market growth during the next few years. Also, collaborations and partnerships for r and d in immunology and advanced diagnostic technologies in immunology will lead to sizable demand in the market.

The report on the immunology market covers the following areas:

Immunology market sizing
Immunology market forecast
Immunology market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunology market vendors that include 3SBio Inc., AbbVie Inc., Amgen Inc., Antares Pharma Inc., Astellas Pharma Inc., Biogen Inc., Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Horizon Therapeutics Plc, ImmuNext Inc., Incyte Corp., Johnson and Johnson Services Inc., Merck KGaA, Mitsubishi Chemical Group Corp., Novartis AG, Pfizer Inc., Takeda Pharmaceutical Co. Ltd., UCB SA, and GlaxoSmithKline Plc. Also, the immunology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR71364

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global immunology market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global immunology market 2017 - 2021 ($ billion)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Immunosuppressants - Market size and forecast 2022-2027
Exhibit 34: Chart on Immunosuppressants - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Immunosuppressants - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Immunosuppressants - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Immunosuppressants - Year-over-year growth 2022-2027 (%)
6.4 Immuno boosters - Market size and forecast 2022-2027
Exhibit 38: Chart on Immuno boosters - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Immuno boosters - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Immuno boosters - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Immuno boosters - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ billion)
Exhibit 43: Data Table on Market opportunity by Type ($ billion)

7 Market Segmentation by Distribution Channel

7.1 Market segments
Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 46: Chart on Comparison by Distribution Channel
Exhibit 47: Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacies - Market size and forecast 2022-2027
Exhibit 48: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 49: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 50: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
7.4 Retail pharmacies - Market size and forecast 2022-2027
Exhibit 52: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 53: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 54: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
7.5 Online pharmacies - Market size and forecast 2022-2027
Exhibit 56: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 57: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 58: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 60: Market opportunity by Distribution Channel ($ billion)
Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 111: AbbVie Inc. - Overview
Exhibit 112: AbbVie Inc. - Product / Service
Exhibit 113: AbbVie Inc. - Key news
Exhibit 114: AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Exhibit 115: Amgen Inc. - Overview
Exhibit 116: Amgen Inc. - Product / Service
Exhibit 117: Amgen Inc. - Key offerings
12.5 Astellas Pharma Inc.
Exhibit 118: Astellas Pharma Inc. - Overview
Exhibit 119: Astellas Pharma Inc. - Product / Service
Exhibit 120: Astellas Pharma Inc. - Key news
Exhibit 121: Astellas Pharma Inc. - Key offerings
12.6 Bristol Myers Squibb Co.
Exhibit 122: Bristol Myers Squibb Co. - Overview
Exhibit 123: Bristol Myers Squibb Co. - Product / Service
Exhibit 124: Bristol Myers Squibb Co. - Key news
Exhibit 125: Bristol Myers Squibb Co. - Key offerings
12.7 Eli Lilly and Co.
Exhibit 126: Eli Lilly and Co. - Overview
Exhibit 127: Eli Lilly and Co. - Product / Service
Exhibit 128: Eli Lilly and Co. - Key news
Exhibit 129: Eli Lilly and Co. - Key offerings
12.8 F. Hoffmann La Roche Ltd.
Exhibit 130: F. Hoffmann La Roche Ltd. - Overview
Exhibit 131: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 132: F. Hoffmann La Roche Ltd. - Key news
Exhibit 133: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 134: F. Hoffmann La Roche Ltd. - Segment focus
12.9 GlaxoSmithKline Plc
Exhibit 135: GlaxoSmithKline Plc - Overview
Exhibit 136: GlaxoSmithKline Plc - Business segments
Exhibit 137: GlaxoSmithKline Plc - Key news
Exhibit 138: GlaxoSmithKline Plc - Key offerings
Exhibit 139: GlaxoSmithKline Plc - Segment focus
12.10 Incyte Corp.
Exhibit 140: Incyte Corp. - Overview
Exhibit 141: Incyte Corp. - Product / Service
Exhibit 142: Incyte Corp. - Key offerings
12.11 Johnson and Johnson Services Inc.
Exhibit 143: Johnson and Johnson Services Inc. - Overview
Exhibit 144: Johnson and Johnson Services Inc. - Business segments
Exhibit 145: Johnson and Johnson Services Inc. - Key news
Exhibit 146: Johnson and Johnson Services Inc. - Key offerings
Exhibit 147: Johnson and Johnson Services Inc. - Segment focus
12.12 Merck KGaA
Exhibit 148: Merck KGaA - Overview
Exhibit 149: Merck KGaA - Business segments
Exhibit 150: Merck KGaA - Key news
Exhibit 151: Merck KGaA - Key offerings
Exhibit 152: Merck KGaA - Segment focus
12.13 Mitsubishi Chemical Group Corp.
Exhibit 153: Mitsubishi Chemical Group Corp. - Overview
Exhibit 154: Mitsubishi Chemical Group Corp. - Business segments
Exhibit 155: Mitsubishi Chemical Group Corp. - Key offerings
Exhibit 156: Mitsubishi Chemical Group Corp. - Segment focus
12.14 Novartis AG
Exhibit 157: Novartis AG - Overview
Exhibit 158: Novartis AG - Business segments
Exhibit 159: Novartis AG - Key offerings
Exhibit 160: Novartis AG - Segment focus
12.15 Pfizer Inc.
Exhibit 161: Pfizer Inc. - Overview
Exhibit 162: Pfizer Inc. - Product / Service
Exhibit 163: Pfizer Inc. - Key news
Exhibit 164: Pfizer Inc. - Key offerings
12.16 Takeda Pharmaceutical Co. Ltd.
Exhibit 165: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 166: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 167: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 168: Takeda Pharmaceutical Co. Ltd. - Key offerings
12.17 UCB SA
Exhibit 169: UCB SA - Overview
Exhibit 170: UCB SA - Product / Service
Exhibit 171: UCB SA - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 172: Inclusions checklist
Exhibit 173: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 174: Currency conversion rates for US$
13.4 Research methodology
Exhibit 175: Research methodology
Exhibit 176: Validation techniques employed for market sizing
Exhibit 177: Information sources
13.5 List of abbreviations
Exhibit 178: List of abbreviations